David McElligott
Pulmonary Disease · Naperville, ILNPI 1578579850
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (59.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Grifols USA, LLC at 45.2% of the total. Reporting peaked in 2019 at $4,563 and has fallen 95.3% since, to $213 in 2021.
Across 214 payments — averaging $29.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Grifols USA, LLC$3K
- GSK$787
- Boehringer Ingelheim$780
- AstraZeneca$644
- Mylan Specialty L.p.$434
- Genentech USA, Inc.$196
- plus $639 from 14 others
What the payments were for
- Speaking & faculty fees$2,00031%
- Travel & lodging$5649%
- Food & beverage$3,78760%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Grifols USA, LLC | 7 | $2,872 |
| GSK | 64 | $787 |
| Boehringer Ingelheim | 36 | $780 |
| AstraZeneca | 35 | $644 |
| Mylan Specialty L.p. | 23 | $434 |
| Genentech USA, Inc. | 10 | $196 |
| Sunovion Pharmaceuticals Inc. | 8 | $112 |
| Electromed, Inc. | 8 | $97 |
| Jazz Pharmaceuticals Inc. | 4 | $72 |
| Teva Pharmaceuticals USA, Inc. | 4 | $65 |
| Advanced Respiratory, Inc | 3 | $57 |
| Actelion Pharmaceuticals US, Inc. | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Philips North America LLC | 2 | $33 |
| Amgen | 1 | $24 |
| Sanofi | 1 | $24 |
| Johnson & Johnson | 1 | $23 |
| Shire North American Group Inc | 1 | $19 |
| Bard Peripheral Vascular, Inc. | 1 | $16 |
| Mayne Pharma Commercial LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolastin-C Liquid$2,811
How this compares
$6,351 in reported general payments places this provider in the 70th percentile of 539 pulmonary disease providers in Illinois.
Other pulmonary disease in Naperville
- Juan FloresNaperville$91K
- Rajive TandonNaperville$47K
- Jasshan MehrotraNaperville$31K
- Douglas HogarthChicago$2.9M
- Steven WhiteChicago$970K
- Momen WahidiChicago$779K
- Septimiu MurguChicago$633K
- Ayodeji AdegunsoyeChicago$561K
- Kristopher McDonoughJoliet$461K
- Ravi KalhanChicago$375K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.